Cargando…
Epigenetics of hepatocellular carcinoma
In recent years, large scale genomics and genome-wide studies using comprehensive genomic tools have reshaped our understanding of cancer evolution and heterogeneity. Hepatocellular carcinoma, being one of the most deadly cancers in the world has been well established as a disease of the genome that...
Autores principales: | Toh, Tan Boon, Lim, Jhin Jieh, Chow, Edward Kai-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500786/ https://www.ncbi.nlm.nih.gov/pubmed/31056726 http://dx.doi.org/10.1186/s40169-019-0230-0 |
Ejemplares similares
-
Epigenetics in cancer stem cells
por: Toh, Tan Boon, et al.
Publicado: (2017) -
Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
por: Lim, Jhin Jieh, et al.
Publicado: (2022) -
JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020) -
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
por: Lim, Jhin Jieh, et al.
Publicado: (2022) -
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression
por: Chong, Yong Chun, et al.
Publicado: (2020)